Those New Pickleball Courts? Thank Ozempic.
Philanthropies with large stakes in weight-loss drugmakers Eli Lilly and Novo Nordisk have surged in value and are now among the biggest in the world.
Related Articles
Is Your Cancer Test Accurate? The FDA Wants to Make Sure
A new rule details how the agency will oversee the $10 billion industry for medical tests conducted by single laboratories.
Less Is More: The Case for ‘Slow Productivity’ at Work
We’re thinking about productivity at work all wrong, Cal Newport says. But how do we tell the boss that?
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
Other longevity researchers have rebuked the Harvard geneticist. “The selling is a step too far,” said one.
Opinion | On Columbia University and Coach Handbags
A degree’s value, in both money and status, depends on the reputation of the institution’s brand.
The New, More-Hopeful Face of Alzheimer’s Disease
Advances in early detection and management of the disease have changed the way patients view an Alzheimer’s diagnosis—and how they live with it.
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
Other longevity researchers have rebuked the Harvard geneticist. “The selling is a step too far,” said one.
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
Other longevity researchers have rebuked the Harvard geneticist. “The selling is a step too far,” said one.
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
Other longevity researchers have rebuked the Harvard geneticist. “The selling is a step too far,” said one.
Meet the AI Expert Advising the White House, JPMorgan, Google and the Rest of Corporate America
Ethan Mollick at the University of Pennsylvania has become the go-to authority on the new technology
Investors Cheer AI Spending Boom in Big Tech—Just Not at Meta
Meta had its worst trading day in 18 months after warning of years of AI investment. Shares of Microsoft and Google parent Alphabet rallied.
